Evidence map›Paper›PMID 32619242›Full record

ArticleThe American journal of clinical nutrition2020

Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study.

Sabina Sieri, Claudia Agnoli, Sara Grioni, Elisabete Weiderpass, Amalia Mattiello, Ivonne Sluijs, Maria Jose Sanchez, Marianne Uhre Jakobsen, Michael Sweeting, Yvonne T van der Schouw and 35 more

Open access · goldAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Tackling Atherosclerosis via Selected Nutrition.International journal of molecular sciences · 2022
    Review
  12. Tolerable upper intake level for dietary sugars.EFSA journal. European Food Safety Authority · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 9 countries.

Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Claudia AgnoliEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Elisabete WeiderpassInternational Agency for Research on Cancer, WHO, Lyon, France.
Amalia MattielloDepartment of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Ivonne SluijsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Maria Jose SanchezAndalusian School of Public Health, Granada, Spain.
Marianne Uhre JakobsenNational Food Institute, Division for Diet, Disease Prevention, and Toxicology, Technical University of Denmark, Kongens Lyngby, Denmark.
Michael SweetingMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Yvonne T van der SchouwJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Lena Maria NilssonDepartment of Public Health and Clinical Medicine, Sustainable Health, Umeå University, Umeå, Sweden.
Patrik WennbergDepartment of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.
Verena A KatzkeCancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Tilman KühnCancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Tammy Y N TongCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Moreno-Iribas ConchiPublic Health Institute of Navarra, IdiSNA, Pamplona, Spain.
José Ramón QuirósPublic Health Directorate, Asturias, Spain.
Juan Manuel García-TorrecillasHospital Universitario Torrecárdenas, Almería, Spain.
Olatz MokoroaPublic Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.
Jesús-Humberto GómezDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Anne TjønnelandDiet, Genes, and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Emiliy SonestedtNutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Elissavet ValanouHellenic Health Foundation, Athens, Greece.
Jolanda M A BoerNational Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
W M Monique VerschurenNational Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Marie-Christine Boutron-RuaultCenter for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Guy FagherazziCenter for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Anne-Laure MadikaCenter for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Manuela M BergmannDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
Pietro FerrariInternational Agency for Research on Cancer, WHO, Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer, WHO, Lyon, France.
Hannah LennonInternational Agency for Research on Cancer, WHO, Lyon, France.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention, Turin, Italy.
Giovanna MasalaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
Rosario TuminoCancer Registry and Histopathology Department, "Civic-M.P.Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.
Elio RiboliDepartment of Epidemiology and Public Health, Imperial College London, London, United Kingdom.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
John DaneshMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Adam S ButterworthMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Vittorio KroghEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Centre international de recherche sur le cancer · FRFondazione IRCCS Istituto Nazionale dei Tumori · ITUniversity of Cambridge · GBGerman Cancer Research Center · DEHellenic Health Foundation · GRNational Institute for Public Health and the Environment · NLUmeå University · SEUniversité Paris-Saclay · FRUtrecht University · NLAarhus University · DKAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESComplejo Hospitalario Torrecárdenas · ESFederico II University Hospital · ITGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESImperial College London · GBInstituto Murciano de Investigación Biosanitaria · ESLund University · SENational and Kapodistrian University of Athens · GR

Funding

British Heart Foundation RG/08/014British Heart Foundation RG/13/13/30194British Heart Foundation RG13/13/30194British Heart Foundation SP/09/002European Research Council 268834Medical Research Council G0800270Medical Research Council MC_UU_00006/1Medical Research Council MC_UU_00006/3Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Medical Research Council MR/L003120/1World Health Organization 001
6 · The paper itself

Abstract

backgroundHigh carbohydrate intake raises blood triglycerides, glucose, and insulin; reduces HDLs; and may increase risk of coronary heart disease (CHD). Epidemiological studies indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased CHD risk.

objectivesThe aim of this study was to determine whether dietary GI, GL, and available carbohydrates are associated with CHD risk in both sexes.

methodsThis large prospective study-the European Prospective Investigation into Cancer and Nutrition-consisted of 338,325 participants who completed a dietary questionnaire. HRs with 95% CIs for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariate-adjusted Cox proportional hazard models.

resultsAfter 12.8 y (median), 6378 participants had experienced a CHD event. High GL was associated with greater CHD risk [HR 1.16 (95% CI: 1.02, 1.31) highest vs. lowest quintile, p-trend 0.035; HR 1.18 (95% CI: 1.07, 1.29) per 50 g/day of GL intake]. The association between GL and CHD risk was evident in subjects with BMI (in kg/m2) ≥25 [HR: 1.22 (95% CI: 1.11, 1.35) per 50 g/d] but not in those with BMI <25 [HR: 1.09 (95% CI: 0.98, 1.22) per 50 g/d) (P-interaction = 0.022). The GL-CHD association did not differ between men [HR: 1.19 (95% CI: 1.08, 1.30) per 50 g/d] and women [HR: 1.22 (95% CI: 1.07, 1.40) per 50 g/d] (test for interaction not significant). GI was associated with CHD risk only in the continuous model [HR: 1.04 (95% CI: 1.00, 1.08) per 5 units/d]. High available carbohydrate was associated with greater CHD risk [HR: 1.11 (95% CI: 1.03, 1.18) per 50 g/d]. High sugar intake was associated with greater CHD risk [HR: 1.09 (95% CI: 1.02, 1.17) per 50 g/d].

conclusionsThis large pan-European study provides robust additional support for the hypothesis that a diet that induces a high glucose response is associated with greater CHD risk.

Indexed as

Glycemic IndexGlycemic LoadAdultAgedCohort StudiesCoronary Artery DiseaseEuropeFemaleHumansMaleMiddle AgedRisk Assessmentcohort studycoronary heart diseaseEPIC-CVD studyEPIC studyglycemic indexglycemic load

Identifiers

PMID32619242
PMCPMC7458777
OpenAlexW3039191454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.